Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$168K Sell
1,396
-94
-6% -$10.9K 0.12% 99
2025
Q4
$157K Buy
1,490
+382
+34% +$35.9K 0.12% 119
2025
Q3
$93K Sell
1,108
-15
-1% -$1.24K 0.07% 175
2025
Q2
$88.9K Sell
1,123
-61
-5% -$4.85K 0.08% 179
2025
Q1
$106K Sell
1,184
-521
-31% -$48.6K 0.1% 154
2024
Q4
$170K Buy
+1,705
New +$176K 0.16% 110

Other funds holding MRK

WPG Advisers's MRK Position: Q1 2026 in Review

WPG Advisers reduced its Merck (MRK) stake by 6.3% in Q1 2026, selling an estimated $10.9K and leaving 1,396 shares worth $168K. The position accounts for 0.12% of the portfolio, ranked #99.

WPG Advisers first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $170K in Q4 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • WPG Advisers held 1,396 shares of Merck worth $168K as of Q1 2026.
  • WPG Advisers sold 94 Merck shares in Q1 2026, an estimated $10.9K.
  • Merck made up 0.12% of WPG Advisers's portfolio in Q1 2026, its #99 holding.
  • WPG Advisers first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • WPG Advisers's Merck position peaked at $170K in Q4 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on WPG Advisers's 13F filing for Q1 2026, filed 30 Apr 2026.